What is BioCryst Pharmaceuticals's income tax?

BioCryst Pharmaceuticals (BCRX) reported income tax of $1M in Q1 2026.

How has BioCryst Pharmaceuticals's income tax changed year-over-year?

BioCryst Pharmaceuticals's income tax increased by 38.3% year-over-year, from $726K to $1M.

What is the long-term trend for BioCryst Pharmaceuticals's income tax?

Over 3 years (2021 to 2025), BioCryst Pharmaceuticals's income tax has grown at a 16.1% compound annual growth rate (CAGR), from $2.25M to $3.53M.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

BioCryst Pharmaceuticals BCRX Income Tax

Income Tax at other companies

Ionis PharmaceuticalsIONS

$218K+87.9%

Ultragenyx PharmaceuticalRARE

$1M0.0%

Arrowhead ResearchARWR

$7K-99.6%

ALN

Alnylam PharmaceuticalsALNY

$15.66M-1.4%

PrecigenPGEN

$0—

Acadia PharmaceuticalsACAD

$344K-96.1%

Segments

By segment

See full

Reportable Segment$1M+38.3%

Other financials

Income statement

See full

Revenue$156.4M+7.5%

Gross profit$151.0M+7.1%

Operating income-$701.6M-3,405%

Net income-$721.8M-2,255,763%

EPS (diluted)-$2.98—

Balance sheet

See full

Cash & equivalents$173.4M+62.2%

Total debt$411.8M+24.7%

Total equity-$553.8M-22.6%

Total assets$465.1M-3.1%

Cash flow

See full

Operating cash flow-$61.8M-125%

CapEx$403.0K+182%

Free cash flow-$62.2M-125%

Valuation

See full

Market cap$2.37B+52.3%

Enterprise value$2.6B+46.7%

P/S2.7×-0.4×

Profitability

See full

Gross margin97.8%+0.8pp

Operating margin-43.1%-49.7pp

Net margin-51.7%-69.7pp

FCF margin35%—

Returns & leverage

See full

Return on equity-882.8%—

Debt / equity0.1×—

Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is BioCryst Pharmaceuticals's income tax?: BioCryst Pharmaceuticals (BCRX) reported income tax of $1M in Q1 2026.
How has BioCryst Pharmaceuticals's income tax changed year-over-year?: BioCryst Pharmaceuticals's income tax increased by 38.3% year-over-year, from $726K to $1M.
What is the long-term trend for BioCryst Pharmaceuticals's income tax?: Over 3 years (2021 to 2025), BioCryst Pharmaceuticals's income tax has grown at a 16.1% compound annual growth rate (CAGR), from $2.25M to $3.53M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.